Valuation: Biogen Inc.

Market Cap 2.96TCr 2.6TCr 2.42TCr 2.23TCr 4.17TCr 2,86800Cr 4.25TCr 29TCr 11TCr 1,39900Cr 11TCr 11TCr 4,85400Cr P/E 2026 *
24.4x
P/E 2027 * 16x
Enterprise Value 3.49TCr 3.07TCr 2.85TCr 2.63TCr 4.92TCr 3,38300Cr 5.01TCr 34TCr 13TCr 1,65000Cr 13TCr 13TCr 5,72500Cr EV / Sales 2026 *
3.47x
EV / Sales 2027 * 3.18x
Free-Float
85.96%
Yield 2026 *
-
Yield 2027 * -
1 day-1.49%
1 week+3.91%
Current month+7.91%
1 month+7.91%
3 months+11.20%
6 months+22.41%
Current year+19.23%
1 week 176.32
Extreme 176.32
186.06
1 month 165.54
Extreme 165.54
193
Current year 134.7
Extreme 134.7
193
1 year 108.8
Extreme 108.8
193
3 years 99
Extreme 99
255.6
5 years 99
Extreme 99
317.45
10 years 99
Extreme 99
351.7
Manager TitleAgeSince
Chief Executive Officer 66 14/11/2022
Director of Finance/CFO 60 01/03/2025
Chief Tech/Sci/R&D Officer - 01/01/2021
Director TitleAgeSince
Director/Board Member 69 23/03/2010
Director/Board Member 77 01/01/2010
Director/Board Member 72 19/06/2019
Change 5-day change 1-year change 3-year change Capi.($)
-1.48%+3.91% - - 2.96TCr
+0.11%-3.98%+13.89%-11.26% 6.63TCr
+0.37%+1.96%+36.39%+199.68% 5.26TCr
+0.51%+37.90%+37.90%+37.90% 4.33TCr
-1.32%-7.38%-57.63%-57.10% 3.86TCr
+0.78%+0.03%+65.07%+81.90% 2.33TCr
-1.81%-9.71%+64.46%-54.90% 2.26TCr
-2.47%-0.28%+0.57%+167.17% 2.02TCr
-0.28%-1.59%+66.57%+119.96% 1.63TCr
+0.33%+3.28%+79.54%+142.98% 1.63TCr
Average -0.53%-2.09%+34.09%+69.59% 3.33TCr
Weighted average by Cap. -0.36%-2.14%+25.42%+58.47%

Financials

2026 *2027 *
Net sales 1.01TCr 885.51Cr 822.64Cr 756.6Cr 1.42TCr 98TCr 1.44TCr 9.84TCr 3.84TCr 48TCr 3.78TCr 3.7TCr 1,65000Cr 1.03TCr 907.4Cr 842.97Cr 775.3Cr 1.45TCr 1LCr 1.48TCr 10TCr 3.93TCr 49TCr 3.87TCr 3.79TCr 1,69100Cr
Net income 128.91Cr 113.38Cr 105.33Cr 97Cr 181.67Cr 12TCr 184.92Cr 1.26TCr 491.27Cr 6.09TCr 483.96Cr 473.49Cr 21TCr 198.64Cr 174.71Cr 162.3Cr 149.27Cr 279.94Cr 19TCr 284.95Cr 1.94TCr 757.01Cr 9.38TCr 745.75Cr 729.62Cr 33TCr
Net Debt 531.54Cr 467.49Cr 434.3Cr 399.43Cr 749.07Cr 51TCr 762.5Cr 5.19TCr 2.03TCr 25TCr 2TCr 1.95TCr 87TCr 322.72Cr 283.84Cr 263.68Cr 242.51Cr 454.8Cr 31TCr 462.95Cr 3.15TCr 1.23TCr 15TCr 1.21TCr 1.19TCr 53TCr
Logo Biogen Inc.
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (72%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (7.4%) ; - other (20.6%): primarily revenues from partnership agreements.
Employees
7,500
Date Price Change Volume
23/26/23 178.78 +1.40% 0
22/26/22 €176.32 -0.23% 1,003
21/26/21 €176.72 -1.03% 0
20/26/20 €178.56 -1.74% 63
17/26/17 €181.72 +5.61% 6
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
35
Last Close Price
200.62USD
Average target price
227.59USD
Spread / Average Target
+13.45%

Quarterly revenue - Rate of surprise